hotspot -WSS

hotspot

author：leisure time 2025-09-05 11:28:06 - browse：675

European Medicines Agency Suffers Cyber Attack in Amsterdam — Paulo Amorim / VWPics via AP Images

LONDON — European regulators on Friday reiterated their view that an ALS treatment from Amylyx Pharmaceuticals should not be approved, likely dooming the drug’s chances for now.

A European Medicines Agency committee had initially recommended against approving the drug, known as Albrioza, in June. Friday’s confirmation of that position came after the company appealed the decision. While the European Commission officially decides whether to approve a new medicine, it almost always follows the committee’s guidance. The final decision is expected to be made before the end of the year.

The drug, which won approval last year in the United States and is marketed Relyvrio, is designed to slow the progression of the fatal neurological condition. In its pivotal trial, patients who received the drug over 24 weeks scored about two points better on a 48-point scale of symptoms than those who got a placebo, indicating the drug slowed disease progression.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： More tobacco lobbyists active in statehouses

WSS

Ozempic has benefits for kidney disease as well as diabetes

Families look for replacement for GSK asthma drug Flovent

Key Senate committee drafts bipartisan bill to stem drug shortages

Why does health care cost so much? A reading guide

First over

FTC falls short on scrutinizing hospital mergers, study says

knowledge

hotspot

Wikipedia

United colonoscopy coverage change 'may cost lives,' doctors say

Cancer researcher Catriona Jamieson is sending tumors into space

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Q&A: Jennifer Adair on making gene therapy available globally

How one medical school became remarkably diverse

Ancient Greek ideas underpin modern concepts of pregnancy

At least 13 dead in Texas as scorching temps continue

For AI in health care standards, federal regulators join with industry group

In Memoriam: Notable people who died in 2023

H5N1 bird flu found in pasteurized milk: what we know

explore

UnitedHealth financials solid despite Change Healthcare cyberattack

Dogs on Prozac: What pet anti

FTC falls short on scrutinizing hospital mergers, study says

He's 19 months old and has one of the world’s rarest diseases

Ozempic has benefits for kidney disease as well as diabetes

MassMutual is introducing free genetic testing for members

hotspot

explore

Wikipedia

focus